A new study found men with breast cancer have higher mortality compared with women, possibly due to lack of awareness.
Christina Bennett, MS
Researchers examined how metformin and TKI therapy did in combatting lung cancer.
New trial results examine whether there's a drug superior to sorafenib when it comes to treating kidney cancer.
There's been much research done on how cancer of the reproductive organs affects patients' sexuality; this new study included patients with cancers outside the reproductive organs.
Whether a cancer survivor had a health savings account (HSA) as part of their high-deductible health plan was linked to access to care.
Study researchers polled 607 women who'd been previously diagnosed with breast cancer to see how recovery time, surgical complications, and cost factored into their decision to receive surgery during treatment.
A new study shows patients with advanced non–small-cell lung cancer have preferences on which chemotherapy side effects they'd prefer to avoid which highlights the importance of incorporating patient preferences into treatment.
A new combo may benefit patients with HER-2 positive metastatic breast cancer, according to a new study.
A pooled analysis included extended-survival data from COMBI-d and COMBI-v trials, both of which included treatment-naïve patients with unresectable or metastatic melanoma who were randomized to receive either dabrafenib plus trametinib or BRAF inhibitor monotherapy.
A total of 30 patients were enrolled in an expansion cohort for relapsed/refractory primary mediastinal B-cell lymphoma and received nivolumab and brentuximab vedotin.